|
| Kwadwo Opoku-Nsiah | Department of Pharmaceutical Chemistry, University of California San Francisco |
| Kwadwo Opoku-Nsiah | Institute for Neurodegenerative Disease, University of California San Francisco |
| Andr??s Hern??ndez | Scripps Research Institute |
| Sarah K Williams | Department of Pharmaceutical Chemistry, University of California San Francisco |
| Sarah K Williams | Institute for Neurodegenerative Disease, University of California San Francisco |
| Nikita Chopra | Department of Pharmaceutical Chemistry, University of California San Francisco |
| Nikita Chopra | University of California San Francisco |
| Nikita Chopra | Quantitative Biosciences Institute, University of California San Francisco |
| Andrej Sali (CM4AI) | Department of Pharmaceutical Chemistry, University of California San Francisco |
| Andrej Sali (CM4AI) | Quantitative Biosciences Institute, University of California San Francisco |
| Andrej Sali (CM4AI) | University of California San Francisco |
| Andrej Sali (CM4AI) | Department of Pharmaceutical Chemistry, University of California San Francisco |
| Andrej Sali (CM4AI) | University of California San Francisco |
| Andrej Sali (CM4AI) | Quantitative Biosciences Institute, University of California San Francisco |
| Gabriel C Lander | Scripps Research Institute |
| Jason E Gestwicki | Department of Pharmaceutical Chemistry, University of California San Francisco |
| Jason E Gestwicki | Institute for Neurodegenerative Disease, University of California San Francisco |